|
|
||||||||
School of Anatomy and Human Biology, The University of Western Australia, 35 Stirling Hwy Crawley, Perth, Western Australia 6009, Australia
(Requests for offprints should be addressed to B Waddell; Email: bwaddell{at}anhb.uwa.edu.au)
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Albino Wistar rats aged between 9 and 12 weeks were obtained from the Animals Resources Centre (Murdoch, Australia) and maintained under controlled conditions as previously described (Burton & Waddell 1994). Rats were mated overnight and the day on which spermatozoa were present in vaginal smear was designated gestational day 1 (g1). The day of birth, usually g23 in this colony of rats, was designated postnatal day 0 (p0). Pup sex was determined by examination of external genital morphology and litters were standardised to 10 pups before the third day postpartum and, where applicable, were weaned on p30. The onset of puberty was deemed to occur at the time of vaginal opening in females and preputial separation in males (Smith & Waddell 2000). All procedures involving animals were conducted only after approval by the Animal Ethics Committee of The University of Western Australia.
Blood sampling and tissue collection
At g22 pregnant rats were anesthetized with halothane/ nitrous oxide and fetuses removed. Blood samples were obtained by decapitation from 4 female and 4 male g22 fetuses (from a single litter) and pooled to provide sufficient volume. Blood samples were collected from anesthetised rats at p12 by decapitation, and at p30 and p51 via the exposed dorsal aorta. Brains were removed from rats at p51 and 7 months of age and the hypothalamus dissected (Zakrzewska et al. 1999) and immediately frozen in liquid nitrogen. Tissue samples for Ob-Re mRNA analysis (spleen, liver, adipose, adrenal, testis and epididymis) were obtained from separate groups of anaesthetised male rats at p51 and 7 months and immediately frozen in liquid nitrogen for subsequent real-time quantitative RT-PCR.
Plasma leptin binding activity
Plasma leptin binding activity was assayed as described previously (Gavrilova et al. 1997, Seeber et al. 2002). Briefly, plasma samples (5 µl) were incubated with 5 µl of 125I-leptin (approximately 5 ng/ml and 20 000 c.p.m.) overnight at 4 °C. Sample buffer (20 µl) containing bromo-phenol blue was added, samples were vortexed and electrophoresed in 12% Tris/glycine gels at 160 V. The gel was dried and placed against film for 48 h at 80 °C. The band corresponding to specifically bound 125I-leptin was scanned and leptin binding activity quantified by analysis of pixel intensity using Scion Image analysis software (Release beta 3b; Scion Corporation, Frederick, MD, USA) as previously described (Burton et al. 1998).
Radioimmunoassays
Blood samples collected as described above were centrifuged at 13 000 g for 5 min and plasma stored at 20 °C until assayed. Plasma leptin concentrations were measured using a radioimmunoassay kit supplied by Linco Research (St Charles, MO, USA). The intra- and inter-assay coefficients of variation were 4% and 8% respectively.
Western blot analysis of hypothalamic Ob-Rb
Hypothalamic Ob-Rb protein expression was measured in postpubertal (p51) and adult rats (7 months of age) as previously described (Seeber et al. 2002). Briefly, hypothalami were homogenized (10 mM Tris buffer containing 1.5 mM EDTA, 1 mM DTT, 1 mM PMSF and 100 µg/ml trypsin inhibitor) then centrifuged at 105 000 g for 30 min. Supernatant protein (30 µg) was resolved by 7% SDS-PAGE electrophoresis and transferred to nitrocellulose membrane (Hybond C Super, Amersham Biosciences, Australia). Membranes were blocked in Trisbuffered saline (TBS)-Tween (0.1 M Tris, 0.15 M NaCl, 0.1% Tween-20; pH 7.5) containing 5% non-fat milk powder for 1 h then exposed for 2 h to leptin receptor antibody (K-20, Santa Cruz Biotechnology; 1:400 dilution in TBS-Tween buffer, containing 1% non-fat milk powder). Membranes were washed then incubated with a horseradish peroxidase-conjugated donkey anti-goat secondary antibody (1:5000; Santa Cruz Biotechnology) for 1 h. Immunoreactive bands were visualised using a chemiluminescence detection kit (SuperSignal Substrate, Pierce Chemical, Rockford, IL, USA), with membranes placed against film for 1 min, and resultant images quantified by densitometry using Scion Image analysis software (Release beta 3b) as previously described (Burton et al. 1998).
Real-time quantitative RT-PCR
Total RNA was isolated from various tissues (adipose, liver, spleen, adrenal, testis and epididymis) obtained from postpubertal (p51) and adult (7 months of age) rats using RNAzol (Iso-Tex Diagnostics, Friendswood, TX, USA), except for adipose tissue which used RNeasy Lipid Tissue Mini Kit (Qiagen, Clifton Hill, Australia). The purified RNA (5 µg) was reverse transcribed and the resultant cDNA purified and quantified as previously described (Seeber et al. 2002). Primers specific to rat Ob-Re (Takaya et al. 1996) and L19 as a housekeeping internal control (Orly et al. 1994) were used for amplification and spanned introns to distinguish cDNA from genomic DNA, and external standards were generated from regular PCR products. Quantitative PCR and melting curve analyses were performed in 10 µl reaction volumes in capillary tubes using the LightCycler system (Roche Diagnostics, Indianapolis, IN, USA) as previously described (Smith & Waddell 2002). Fluorescence values were analysed and a standard curve constructed using the LightCycler software, and sample values were expressed relative to L19 expression.
Statistical analysis
All data are expressed as the mean ± S.E.M. where a minimum of three animals were used for each experimental variable and each litter represented an n of one. Variation in plasma leptin binding activity related to age and sex was assessed by one- or two-way ANOVA, and differences among specific means were determined by LSD test (Snedecor & Cochran 1989). Unpaired t-tests were used to compare plasma leptin, leptin binding activity and hypothalamic Ob-Rb protein expression between male and female rats at any given age. For tissue expression of Ob-Re mRNA, the data were first log transformed to adjust for unequal variance, then analysed by two-way ANOVA.
| Results |
|---|
|
|
|---|
Plasma leptin binding activity varied significantly with both age (P<0.001) and sex (P<0.05) and there was significant interaction between these sources of variation (P<0.05; Fig. 1
). Therefore, age-related changes were assessed separately in males and females by one way ANOVAS. In females, plasma leptin binding activity increased gradually from very low levels at g22 and p12 to a maximum at 7 months (P<0.05). A more dramatic increase (P<0.001) was observed in male rats, rising more than three-fold from pre- to post-puberty (P<0.05) and then by a further two-fold from post-puberty to seven months (P<0.05). Therefore, while plasma leptin binding activity was similar in male and female rats at prepubertal stages, it was higher (P<0.05) in males after puberty (p51 and 7 months).
|
We previously demonstrated that hypothalamic Ob-Rb protein expression was higher in females compared with males in the immediate post-pubertal period (Smith & Waddell 2003a). A similar difference in Ob-Rb expression was observed at day 51 in the present work (females 21% greater, P<0.05), but by seven months of age this sex difference was no longer apparent (Fig. 2
). Plasma leptin concentrations at seven months of age were quite variable and did not differ significantly between males (9.0 ± 1.0 ng/ml) and females (6.1 ± 1.0 ng/ml; P=0.10), even though males were 37% heavier than females (males, 533 ± 5 g; females, 334 ± 9 g; P<0.001).
|
Expression of mRNA encoding the Ob-Re isoform of the leptin receptor was detected in all tissues examined at day 51 and at 7 months (Fig. 3
). Expression levels varied with both age (P<0.01) and tissue (P<0.01) and there was significant interaction between these sources of variation (P<0.01). Therefore, specific age comparisons were made by unpaired t-tests and these showed age-related increases in Ob-Re mRNA expression in the spleen (300-fold increase, P<0.01), testis (2.4-fold, P<0.05) and adipose tissue (2-fold, P<0.05).
|
| Discussion |
|---|
|
|
|---|
The developmental increase in plasma leptin binding activity was clearly more pronounced in males than females, rising several-fold between late fetal life and adulthood. Because this sex difference emerged only after puberty it may reflect the action of sex steroids, with testosterone stimulating and/or ovarian steroids inhibiting tissue expression of Ob-Re. Estrogen appears to suppress Ob-Rb expression in the rat choroid plexus, hypothalamus (Bennett et al. 1999) and ovary (Duggal et al. 2002), although in the baboon placenta estrogen suppression induced by fetectomy was recently shown to reduce placental expression of the long form of Ob-R (Edwards et al. 2004). Interestingly, a putative estrogen response element has been identified on the Ob-R promoter in the rat (Lindell et al. 2001), but it remains unclear how this might influence tissue expression of the specific Ob-R isoforms, including Ob-Re. In humans, plasma leptin binding activity is also higher in males but, surprisingly, plasma leptin binding activity is associated negatively with plasma testosterone in males and positively with estrogen in females (Mann et al. 2003). Clearly, further studies are required to determine the mechanisms underlying sex differences in plasma leptin binding activity in both rodents and humans.
The increase in plasma leptin binding is likely to reduce the MCR of leptin relative to body weight, an effect recently observed in rat pregnancy (Smith & Waddell 2003b). This reduction in leptin MCR occurred just prior to term, coincident with maximal levels of leptin binding activity (Smith & Waddell 2003b) and likely reflects retention of leptin within the vascular compartment. During early postnatal development plasma leptin levels exhibit a dynamic pattern in both males and females, but then after puberty leptin rises more quickly in male rats (Smith & Waddell 2003a). The present study suggests that this divergence partly reflects the more rapid increase in plasma leptin binding activity and the associated fall in relative MCR of leptin in males.
In addition to limiting leptin metabolism, increased plasma leptin binding activity is likely to restrict leptin access to Ob-Rb on target cells and thus result in a state of relative leptin resistance, comparable to that apparent in pregnancy (Gavrilova et al. 1997, Seeber et al. 2002). This effect of leptin binding may contribute to the greater body weight and associated increased body fat percentage of male relative to female rats (Reed et al. 1930). Indeed, age-related hyperleptinemia and increased food intake occur in male rats in association with reduced hypothalamic uptake of leptin (Fernandez-Galaz et al. 2001), and similar effects have been observed in diet-induced rodent models of obesity (Halaas et al. 1997, Van Heek et al. 1997, El-Haschimi et al. 2000). Interestingly, the present work confirms the clear sex difference (males>females) in hypothalamic Ob-Rb protein expression previously reported for rats aged 51 days (Smith & Waddell 2003a), but shows that this sex difference is lost by 7 months, coincident with a reduction in the sex difference in plasma leptin. Thus, the rise in plasma leptin in females between post-puberty and seven months of age may reflect a more leptin resistant state due to lower hypothalamic Ob-Rb.
While the placenta is clearly recognised as a major source of Ob-Re and thus plasma leptin binding activity in pregnant rodents (Gavrilova et al. 1997, Lammert et al. 2002, Smith & Waddell 2002), the source of circulating Ob-Re in non-pregnant rodents has remained uncertain. Thus, one previous report provided no clear indication of Ob-Re mRNA expression by Northern analysis (Fei et al. 1997) whereas another detected Ob-Re mRNA by RT-PCR in a range of tissues but without accurate quantitation (Lollmann et al. 1997). We subsequently used quantitative RT-PCR to demonstrate Ob-Re mRNA expression in the hypothalamus of both male and female rats, and to show a clear developmental increase in this expression in females (Smith & Waddell 2003a). The present work extends these observations by showing that Ob-Re mRNA is expressed by several other tissues, most notably in the spleen where it increased more than 300-fold from the immediate post-pubertal period to the adult. A role for leptin in the immune system is well recognised (Fantuzzi & Faggioni 2000, Loffreda et al. 1998) and the spleen is known to express both Ob-Rb (Gainsford et al. 1996, Lollmann et al. 1997) and Ob-Re (Lollmann et al. 1997). Potentially, Ob-Re could play a local regulatory role within the spleen by mediating leptin access to Ob-Rb, and splenic secretion of Ob-Re into the general circulation is likely to contribute significantly to plasma leptin binding activity. Among the other tissues examined, Ob-Re mRNA expression appeared relatively low, particularly in the adult, and as such these are likely to make only a relatively minor contribution to circulating Ob-Re.
In contrast to Ob-Re mRNA expression by several tissues in rodents, circulating leptin binding activity in humans is generated entirely by ectodomain shedding of membrane receptors (Maamra et al. 2001, Ge et al. 2002). It is possible that this shedding mechanism also operates in rodents, thus providing an additional source of circulating Ob-Re, but to our knowledge this possibility has not been investigated. In any event, regulation of leptin binding activity is likely to differ substantially between rodents and humans, and in this context it is noteworthy that the increase in plasma leptin binding activity from pre- to post-puberty in rats is opposite to the decrease in humans (Quinton et al. 1999, Kratzsch et al. 2002, Mann et al. 2003). The latter may facilitate puberty onset in humans by increasing leptin access to its hypothalamic targets, whereas in the rat, increased hypothalamic expression of Ob-Rb (Smith & Waddell 2003a) would appear to be of greater importance to puberty onset.
| References |
|---|
|
|
|---|
Burton PJ & Waddell BJ 1994 11ß-Hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure. Journal of Endocrinology 143 505513.
Burton PJ, Krozowski ZS & Waddell BJ 1998 Immunolocalization of 11ß-hydroxysteroid dehydrogenase types 1 and 2 in rat uterus: variation across the estrous cycle and regulation by estrogen and progesterone. Endocrinology 139 376382.
Campfield LA, Smith FJ, Guisez Y, Devos R & Burn P 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269 546549.
Cheung CC, Thornton JE, Kuijper JL, Weigle DS, Clifton DK & Steiner RA 1997 Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology 138 855858.
Clarke IJ & Henry BA 1999 Leptin and reproduction. Reviews in Reproduction 4 4855.
Duggal PS, Weitsman SR, Magoffin DA & Norman RJ 2002 Expression of the long (OB-RB) and short (OB-RA) forms of the leptin receptor throughout the oestrous cycle in the mature rat ovary. Reproduction 123 899905.[Abstract]
Edwards DE, Bohm RP Jr, Purcell J, Ratterree MS, Swan KF, Castracane VD, Henson MC 2004 Two isoforms of the leptin receptor are enhanced in pregnancy-specific tissues and soluble leptin receptor is enhanced in maternal serum with advancing gestation in the baboon. Biology of Reproduction 71 17461752.
Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA, Ogawa Y, Liu X, Ware SM, Craigen WJ et al. 2004 Serum leptin level is a regulator of bone mass. PNAS 101 32583263.
El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C & Flier JS 2000 Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. Journal of Clinical Investigation 105 18271832.[Web of Science][Medline]
Fantuzzi G & Faggioni R 2000 Leptin in the regulation of immunity, inflammation, and hematopoiesis. Journal of Leukocyte Biology 68 437446.
Fei H, Okano HJ, Li C, Lee GH, Zhao C, Darnell R & Friedman JM 1997 Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. PNAS 94 70017005.
Fernandez-Galaz C, Fernandez-Agullo T, Campoy F, Arribas C, Gallardo N, Andres A, Ros M & Carrascosa JM 2001 Decreased leptin uptake in hypothalamic nuclei with ageing in Wistar rats. Journal of Endocrinology 171 2332.[Abstract]
Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS & Hilton DJ 1996 Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. PNAS 93 1456414568.
Gavrilova O, Barr V, Marcus-Samuels B & Reitman M 1997 Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor. Journal of Biological Chemistry 272 3054630551.
Ge H, Huang L, Pourbahrami T & Li C 2002 Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. Journal of Biological Chemistry 277 4589845903.
Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA & Friedman JM 1997 Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. PNAS 94 88788883.
Henson MC & Castracane VD 2000 Leptin in pregnancy. Biology of Reproduction 63 12191228.
Huang L, Wang Z & Li C 2001 Modulation of circulating leptin levels by its soluble receptor. Journal of Biological Chemistry 276 63436349.
Kastin AJ, Pan W, Maness LM, Koletsky RJ & Ernsberger P 1999 Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 20 14491453.[CrossRef][Web of Science][Medline]
Kratzsch J, Lammert A, Bottner A, Seidel B, Mueller G, Thiery J, Hebebrand J & Kiess W 2002 Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. The Journal of Clinical Endocrinology and Metabolism 87 45874594.
Lammert A, Brockmann G, Renne U, Kiess W, Bottner A, Thiery J & Kratzsch J 2002 Different isoforms of the soluble leptin receptor in non-pregnant and pregnant mice. Biochemical and Biophysical Research Communications 298 798804.[CrossRef][Web of Science][Medline]
Lindell K, Bennett PA, Itoh Y, Robinson ICAF, Carlsson LMS & Carlsson B 2001 Leptin receptor 5' untranslated regions in the rat: relative abundance, genomic organization and relation to putative response elements. Molecular and Cellular Endocrinology 172 3745.[CrossRef][Web of Science][Medline]
Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW et al. 1998 Leptin regulates proinflammatory immune responses. FASEB Journal 12 5765.
Lollmann B, Gruninger S, Stricker-Krongrad A & Chiesi M 1997 Detection and quantification of the leptin receptor splice variants Ob- Ra, b, and, e in different mouse tissues. Biochemical and Biophysical Research Communications 238 648652.[CrossRef][Web of Science][Medline]
Maamra M, Bidlingmaier M, Postel-Vinay MC, Wu Z, Strasburger CJ & Ross RJ 2001 Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology 142 43894393.
Mann DR, Johnson AO, Gimpel T & Castracane VD 2003 Changes in circulating leptin, leptin receptor, and gonadal hormones from infancy until advanced age in humans. The Journal of Clinical Endocrinology and Metabolism 88 33393345.
Nagatani S, Guthikonda P, Thompson RC, Tsukamura H, Maeda KI & Foster DL 1998 Evidence for GnRH regulation by leptin: leptin administration prevents reduced pulsatile LH secretion during fasting. Neuroendocrinology 67 370376.[CrossRef][Web of Science][Medline]
Orly J, Rei Z, Greenberg NM & Richards JS 1994 Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone-induced granulosa cell differentiation: use of reverse transcriptase-polymerase chain reaction assay for multiple messenger ribonucleic acids. Endocrinology 134 23362346.
Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T & Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269 540543.
Quinton ND, Smith RF, Clayton PE, Gill MS, Shalet S, Justice SK, Simon SA, Walters S, Postel-Vinay M-C, Blakemore AIF et al. 1999 Leptin binding activity changes with age: The link between leptin and puberty. The Journal of Clinical Endocrinology and Metabolism 84 23362341.
Reed LL, Yamaguchi F, Anderson WE & Mendel LB 1930 Factors influencing the distribution and character of adipose tissue in the rat. Journal of Biological Chemistry 87 147174.
Seeber RM, Smith JT & Waddell BJ 2002 Plasma leptin binding activity and hypothalamic leptin receptor expression during pregnancy and lactation in the rat. Biology of Reproduction 66 17621767.
Smith JT & Waddell BJ 2000 Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology 141 24222428.
Smith JT & Waddell BJ 2002 Leptin receptor expression in the rat placenta: changes in ob-ra, ob-rb, and ob-re with gestational age and suppression by glucocorticoids. Biology of Reproduction 67 12041210.
Smith JT & Waddell BJ 2003a Developmental changes in plasma leptin and hypothalamic leptin receptor expression in the rat: peripubertal changes and the emergence of sex differences. Journal of Endocrinology 176 313319.[Abstract]
Smith JT & Waddell BJ 2003b Leptin distribution and metabolism in the pregnant rat: transplacental leptin passage increases in late gestation but is reduced by excess glucocorticoids. Endocrinology 144 30243030.
Snedecor GW & Cochran WG 1989 Statistical Methods, Ch 12, edn 8. Ames, Iowa: Iowa State University Press.
Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K & Nakao K 1996 Molecular cloning of rat leptin receptor isoform complementary DNAsidentification of a missense mutation in Zucker fatty (fa/fa) rats. Biochemical and Biophysical Research Communications 225 7583.[CrossRef][Web of Science][Medline]
Tartaglia LA 1997 The leptin receptor. Journal of Biological Chemistry 272 60936096.
Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD & Davis HR Jr 1997 Diet-induced obese mice develop peripheral, but not central, resistance to leptin. Journal of Clinical Investigation 99 385390.[Web of Science][Medline]
Zakrzewska KE, Cusin I, Stricker-Krongrad A, Boss O, Ricquier D, Jeanrenaud B & Rohner-Jeanrenaud F 1999 Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes 48 365370.[Abstract]
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM 1994 Position cloning of the mouse obese gene and its human homologue. Nature 372 425432.[CrossRef][Medline]
Received 22 October 2004
Accepted 8 December 2004
This article has been cited by other articles:
![]() |
W. Pan, H. Hsuchou, H. Tu, and A. J. Kastin Developmental Changes of Leptin Receptors in Cerebral Microvessels: Unexpected Relation to Leptin Transport Endocrinology, March 1, 2008; 149(3): 877 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Desai, D. Gayle, G. Han, and M. G. Ross Programmed Hyperphagia Due to Reduced Anorexigenic Mechanisms in Intrauterine Growth-Restricted Offspring Reproductive Sciences, May 1, 2007; 14(4): 329 - 337. [Abstract] [PDF] |
||||
![]() |
O Verlaeten, C Casery, S Cavagna, D Naville, P Giraudon, M F Belin, M Begeot, and A Bernard Identification of Urop11, a novel leptin-modulated gene that is upregulated in the hypothalamus of mice with virus-induced obesity J. Mol. Endocrinol., January 1, 2007; 38(1): 3 - 17. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |